Substituted 1,6-naphthyridines

The present invention relates to the use of compounds of general formula I wherein R′, R¹, R² and R³ are as

defined herein, or to a pharmaceutically acceptable acid addition salt, to a racemic mixture or to its corresponding enantiomer and/or optical isomers thereof, and for methods to treat a variety of neurodegenerative and neuropsychiatric diseases.

• Request a Brochure
• Request more Info
• Request a Quote